Biophysical properties of a tau seed

[1]  M. Diamond,et al.  Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF , 2021, Acta neuropathologica communications.

[2]  L. Joachimiak,et al.  Regulatory inter-domain interactions influence Hsp70 recruitment to the DnaJB8 chaperone , 2021, Nature Communications.

[3]  L. Joachimiak,et al.  DnaJC7 binds natively folded structural elements in tau to inhibit amyloid formation , 2020, Nature Communications.

[4]  Marie P. Schützmann,et al.  β-Turn exchanges in the α-synuclein segment 44-TKEG-47 reveal high sequence fidelity requirements of amyloid fibril elongation. , 2020, Biophysical chemistry.

[5]  D. Eisenberg,et al.  Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease , 2020, The Journal of Biological Chemistry.

[6]  L. Petrucelli,et al.  Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains , 2020, Cell.

[7]  H. Kampinga,et al.  Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species , 2019, The Journal of Biological Chemistry.

[8]  L. Joachimiak,et al.  Tau local structure shields an amyloid-forming motif and controls aggregation propensity , 2019, Nature Communications.

[9]  A. Murzin,et al.  Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules , 2019, Nature.

[10]  J. Freed,et al.  Cofactors are essential constituents of stable and seeding-active tau fibrils , 2018, Proceedings of the National Academy of Sciences.

[11]  A. Murzin,et al.  Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases , 2018, bioRxiv.

[12]  Min Jae Lee,et al.  Degradation or aggregation: the ramifications of post-translational modifications on tau , 2018, BMB reports.

[13]  M. Diamond,et al.  Tau monomer encodes strains , 2018, bioRxiv.

[14]  H. Lashuel,et al.  Protein Semisynthesis Provides Access to Tau Disease-Associated Post-translational Modifications (PTMs) and Paves the Way to Deciphering the Tau PTM Code in Health and Diseased States. , 2018, Journal of the American Chemical Society.

[15]  Y. Yamaguchi,et al.  Molecular basis for diversification of yeast prion strain conformation , 2018, Proceedings of the National Academy of Sciences.

[16]  David W. Colby,et al.  Inert and seed-competent tau monomers suggest structural origins of aggregation , 2017, bioRxiv.

[17]  A. Murzin,et al.  Cryo-EM structures of Tau filaments from Alzheimer’s disease brain , 2017, Nature.

[18]  H. Braak,et al.  Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue , 2017, Acta neuropathologica communications.

[19]  N. Cairns,et al.  Widespread tau seeding activity at early Braak stages , 2016, Acta Neuropathologica.

[20]  Michael R. Holden,et al.  RNA Binds to Tau Fibrils and Sustains Template-Assisted Growth , 2015, Biochemistry.

[21]  J. Shea,et al.  Regulation and aggregation of intrinsically disordered peptides , 2015, Proceedings of the National Academy of Sciences.

[22]  Nigel J. Cairns,et al.  Proteopathic tau seeding predicts tauopathy in vivo , 2014, Proceedings of the National Academy of Sciences.

[23]  Friedrich Förster,et al.  False discovery rate estimation for cross-linked peptides identified by mass spectrometry , 2012, Nature Methods.

[24]  J. Udgaonkar,et al.  Understanding the Kinetic Roles of the Inducer Heparin and of Rod-like Protofibrils during Amyloid Fibril Formation by Tau Protein* , 2011, The Journal of Biological Chemistry.

[25]  Fei Liu,et al.  Tau in Alzheimer disease and related tauopathies. , 2010, Current Alzheimer research.

[26]  M. Meraz-Ríos,et al.  Tau oligomers and aggregation in Alzheimer’s disease , 2010, Journal of neurochemistry.

[27]  A. Minton,et al.  Quantitative Characterization of Heparin Binding to Tau Protein , 2009, The Journal of Biological Chemistry.

[28]  M. Wolfe.  Tau Mutations in Neurodegenerative Diseases* , 2009, Journal of Biological Chemistry.

[29]  Ruedi Aebersold,et al.  Identification of cross-linked peptides from large sequence databases , 2008, Nature Methods.

[30]  H. Bujard,et al.  The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy , 2008, The Journal of Neuroscience.

[31]  E. M. Jones,et al.  Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: Structural clues for prion propagation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Goedert,et al.  Repeat motifs of tau bind to the insides of microtubules in the absence of taxol , 2003, The EMBO journal.

[33]  E. Mandelkow,et al.  RNA stimulates aggregation of microtubule‐associated protein tau into Alzheimer‐like paired helical filaments , 1996, FEBS letters.